reported that the addition of traditional Chinese acupuncture (TCA) was superior to conservative therapy but not to sham acupuncture for osteoarthritis of the knee. They suggest that "because complete blinding was impossible, this study does not allow us to determine whether the observed effectiveness of TCA and sham acupuncture was due to placebo effects, intensity of provider contact, or a physiologic effect of needling." However, 2 related points need to be emphasized.
TO THE EDITOR:
The impressive finding in the recent study by Scharf and colleagues (1) is that treatment outcomes do not statistically significantly differ between patients treated with sham acupuncture and those treated with real acupuncture. A similar result was reported in a previous study for prophylaxis of migraine (2) . Inherent difficulties in the use of sham acupuncture procedures make interpreting the results difficult. What is verum or real acupuncture? How does it differ from sham acupuncture? Although the study protocol carefully avoided deep insertion and manual stimulation of needles in sham acupunctures, these technical modifications alone do not exclude the possibility that typical acupuncture sensation of deqi can occur. In addition, patients do not have to feel anything on needling for treatment to succeed in some Japanese acupuncture techniques (3) . More important, the choice of real and sham acupuncture points is controversial. Diagnosis procedure of traditional Chinese medicine does not depend on blood tests or biomedical techniques but on observable signs and symptoms that are hardly quantified. Even granting pattern recognition is capable of consistent repeatability at least among acupuncturists of similar training, and theoretical variety for selection of points is considerable among international experts. In addition, exact anatomical locations of many acupuncture points are contentious and international standardization is still under way. Building consensus among experts is necessary for more accurate assessment of sham acupuncture.
Shin-ichi Muramatsu, MD, PhD
Jichi Medical University Tochigi 329-0498, Japan print and online publications have provided details of the study design to the public. In Scharf and colleagues' double-blind study, both patients and telephone interviewers were blinded. The reliability of the study depended on not telling patients that real acupuncture points with deep needling were used in the real acupuncture group and that nonacupuncture points with superficial needling were used in the sham acupuncture or placebo group.
Recruitment for the study ended around February 2004, and the last interview was conducted around October 2004. However, the following resources published the study design before the study began or ended (2-6).
The master plan, version V9.0, which details the sham acupuncture in the ninth chapter (2) , and the study plan, version V4.2, which details the study design in the fourth chapter (3), were made public in 2002. That same year, study authors published an article in the German weekly journal Deutsches Ä rzteblatt (4) . The article states that "in sham acupuncture, needles will be inserted superficially and at defined nonacupuncture points" (author translation). The online edition of the journal is often read by patients, has about 2 080 000 page impressions per month, and published the article without password restriction.
The final and complete study plan was made public online without password restriction (5) . The study authors also published an article (6) that contributed to the wide and unrestricted distribution of study details. Browsing through the Current Controlled Trials registry (www.controlled-trials.com) reveals that it is very unusual to publish a detailed study plan for the nonmedical public before a study ends.
Another drawback of the study is that patients who were experienced in acupuncture were allowed to participate: "Patients, who had acupuncture more than a year ago were allowed to participate, unless it was acupuncture against gonarthrosis" (author translation [5] ).
Unblinded and acupuncture-experienced patients could easily distinguish between minimal and real acupuncture by simply watching the acupuncturist: Superficial needling meant that the patient belonged to the minimal (sham) acupuncture group. Sham acupuncture patients could then reduce their pain with additional therapy. I believe that many unblinded patients from the sham acupuncture group tended to apply additional therapies (for example, aspirin) without telling anyone that they did so. Patients could easily have received even expensive physiotherapy because they were paid a substantial amount of money for joining and completing the study. This might have led them to keep quiet about (forbidden) additional therapies for fear of financial sanctions when telling the truth. I believe that the results of the sham acupuncture group have been improved substantially by additional therapy.
Dieter Wettig, PhD, MD Wiesbaden-Dotzheim 65199, Germany IN RESPONSE: We thank Dr. Pijak and Dr. Muramatsu for their comments and for discussing different possibilities to explain our results. In our paper, we mentioned the following possible reasons for the observed efficacy of acupuncture: effects of needling, more intensive provider interaction, and differences in expectation (placebo effect in the strict sense). Like Dr. Pijak, we do not assume that the superiority of acupuncture can be ascribed entirely to a placebo effect, but we assume that all 3 reasons contribute to the observed effect. We agree that more intensive TCA schemes and less invasive sham acupuncture schemes exist as those chosen in our study, and we agree that the definition of appropriate sham acupuncture is an unsolved problem. Our results suggest that our sham scheme is not a placebo scheme but is probably a real, minimal acupuncture. Furthermore, the definition of an optimal acupuncture concept is still in discussion and whether an optimal point selection exists is questionable. We agree with Dr. Muramatsu that deep needling does not seem to be important for specific acupuncture effects. Specific and nonspecific effects of acupuncture as a complex therapeutic intervention are intertwined (1). Hence, as Dr. Pijak states, investigations with other schemes and devices are necessary to clarify whether there are specific effects of traditional acupuncture techniques. Our study could not answer these questions because it was designed as a pragmatic approach to clarify whether acupuncture as commonly used in German health care is justified as a treatment component for knee pain.
Dr. Wettig is right that we have published our study protocol in advance. He correctly cited articles that informed that our study compared TCA and sham acupuncture. We remain convinced that publication of study protocols in advance is good scientific practice. In addition, we should remind readers that, by ethical reasons in randomized trials, study physicians are obliged to inform the patient about all possible therapies that could be allocated. We doubt that many patients studied the techniques described in the protocol publication in detail to become aware about what type of acupuncture they have received. Our careful analysis showed that patient blinding of acupuncture was successful. Even about half of those patients who were convinced to know the type of acupuncture that they received had incorrect guesses. Moreover, the knowledge of receiving sham acupuncture would not favor the effect in this group but would reduce a placebo effect evoked by the expectation. The constructed conjecture of Dr. Wettig about many unreported additional therapies in the sham acupuncture group is extremely unlikely. The additional therapies, including medication, reported to the blinded interviewer were similar in both acupuncture groups. (1) provide new insights into the J-curve discussion in hypertensive patients with coronary artery disease (CAD). Briefly, they observed an increase in all-cause mortality and myocardial infarctions with lower diastolic blood pressure in patients from the International Verapamil-Trandolapril Study (INVEST) (2), hypertensive patients with CAD, who were treated with a verapamil sustained-release-based or atenolol-based strategy. The authors mention impaired coronary perfusion, increased pulse pressure and arterial stiffness, and underlying chronic illness as possible pathophysiologic mechanisms.
Clearly, we cannot speculate on the latter mechanism, but we would like to support the 2 other explanations. First, the mean patient age in INVEST was 66 years. Generally in this age group, isolated systolic hypertension is by far the most common phenotype of hypertension (3), a condition characterized by widened pulse pressure, increased arterial stiffness, increased or premature arterial wave reflections (therefore decreased diastolic blood pressure), and impaired coronary perfusion (4, 5) . In the original publication, more than 50% of patients had "controlled" diastolic blood pressure at baseline, suggesting isolated systolic hypertension. A complementary analysis in patients with isolated systolic hypertension, if they had been identified at baseline, would be very interesting. Second, Chirinos and colleagues (6), as well as our group (7), recently observed that increased arterial wave reflections, one of the main pathophysiologic principles contributing to an increased pulse pressure in patients with isolated systolic hypertension, are accompanied by an increase in major adverse cardiovascular events, including myocardial infarction and death, in patients with CAD. In the Chirinos and colleagues' paper (6), as well as in a previous study showing a relationship between increased arterial wave reflections and the presence and extent of CAD (8), a lower diastolic blood pressure was a predictor of the unfavorable end point. Moreover, in the latter study, systolic blood pressure was identical in patients with and without CAD, and the statistically significant difference in pulse pressure was mediated mainly by a lower diastolic blood pressure in the CAD group. In other words, the only clue to the altered arterial characteristics in patients with CAD was a lower diastolic blood pressure. Of note, most patients with CAD in that study were treated hypertensive patients with a mean age of 63.8 years and, therefore, were similar to those in the INVEST patient population.
In conclusion, although INVEST did not report arterial properties (1, 2), the increased risk accompanying a lower diastolic blood pressure in treated hypertensive patients with CAD might be explained by increased arterial wave reflections and arterial stiffness. the subspecialties for those who choose to pursue them. I would propose a model where internal medicine training is limited to 2 years for persons interested in pursuing a subspecialty. The third year would be reserved for residents who are interested in general internal medicine. The third year could be tailored to either an extensive inpatient experience for those interested in a hospitalist position or an extensive ambulatory medicine experience for those interested in outpatient medicine. Internal medicine would immediately become more attractive. I propose a thought experiment as indirect evidence. How competitive do you suppose dermatology would be if it required 3 years of internal medicine first? Similarly, how competitive do you suppose anesthesia or radiology would be if 3 to 5 years of general surgery were required first? It is certainly time to rethink how we train internists. I simply feel that the authors have missed the best solution. 
CLINICAL OBSERVATIONS

A Rare Mimic of Hereditary Hemorrhagic Telangiectasia and Conjunctivitis
Background: To our knowledge, no case report of arteriovenous malformation of the brain mimicking hereditary hemorrhagic telangiectasia has been described.
Objective: To describe a case of unilateral retinocephalic vascular malformation mimicking hereditary hemorrhagic telangiectasia and conjunctivitis.
Case Report: A 37-year-old male janitor with a history of spontaneous and recurrent nose bleeding episodes presented with left leg paresis that slowly progressed over 2 years. He also had a right "red eye" and subtle telangiectases on the right side of his face (Figure, A) . Neurologic examination showed left hemiparesis mainly affecting the lower limb, with a left Babinski sign and symmetrical tendon reflexes. Vibration sense and pinprick sensation were preserved. Examination of the eyes showed vascular dilatation of the right bulbar conjunctiva (Figure, A) . Visual acuity was normal in both eyes. According to the patient, the red eye was conjunctivitis that was present since childhood.
Computed tomography and brain magnetic resonance imaging with angiography showed a large cerebral arteriovenous malformation deeply located in the right hemisphere, involving the optic nerve, basal ganglia, and mesencephalon with large drainage into the Galen vein (Figure, B) . Brain angiography showed similar abnormalities. Ophthalmoscopy demonstrated an arteriovenous aneurysm of the right retina confirmed by retinal fluorescein angiography (Figure,  C) and a normal left retina (Figure, D) . Nasofibroscopy was normal. The patient declined endovascular treatment for the cerebral arteriovenous malformation.
The patient fulfilled clinical criteria for the diagnosis of hereditary hemorrhagic telangiectasia (brain arteriovenous malformation, telangiectases, and epistaxis) despite the lack of an affected firstdegree relative (1), but mutation analysis of the 2 known genes responsible for the condition, ENG and ALK1, did not reveal a mutation. Because of the strictly unilateral distribution of cerebral and retinal arteriovenous malformation, a syndrome of unilateral retinocephalic vascular malformation, best known as the Wyburn-Mason syndrome (or the Bonnet-Dechaume-Blanc syndrome), was diagnosed (2, 3) .
Discussion: Unilateral retinocephalic vascular malformation is a rare congenital syndrome that results from an abnormality in the embryonal development of the vessels related to the visual pathways from the mesencephalon to the retina. Clinical findings depend on the extent of the malformations (4). Dermatologic abnormalities of the face are usually subtle, consisting of a faint reddish blush and punctuate telangiectases. Associated arteriovenous malformations of the mouth, nose, or jaw occur in 40% of cases (4) . Epistaxis due to nasal arteriovenous malformations is common. Unilateral dilatation of conjunctival vessels was described first by Bonnet and colleagues (3) and in other cases (5) . The small vessels are not tortuous and do not reach the corneal limbus as in carotid cavernous fistula. Retinal arteriovenous malformations or arteriovenous anastomoses may vary from a single retinal vessel to very extensive involvement of all vessels, which are markedly tortuous and dilated. Retinal arteriovenous malformations are prone to vessel damage and thrombosis (6) . Brain arteriovenous malformations are found in more than 30% of patients with retinal vascular anastomoses (5). Brain arteriovenous malformations manifest with hemiparesis in half of cases, homonymous hemianopsia in half of cases, seizures and headaches in one third of cases, and neuropsychological disturbances in one third of cases. The outcome is generally poor, but some rare cases of spontaneous involution of the malformation have been reported (6) . Endovascular treatment, surgery, physical therapy, and antiepileptic drug therapy are sometimes necessary.
